ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
다우존스 지수
38,675.68
1.18%
Bitcoin
64,304.07
2.25%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Turning Point Therapeutics Inc (TPTX)

  7. Turning Point Therapeutics Inc (TPTX) 뉴스

TPTX

Turning Point Therapeutics (TPTX)

Turning Point Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:TPTX
일자시간출처헤드라인심볼기업
2022/08/3005:31Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/08/2319:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/08/1805:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/08/1805:43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/08/1805:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/08/1805:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/08/1805:33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/08/1805:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/08/1805:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/08/1805:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/08/1722:03Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/08/1722:01Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/08/1722:01Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/08/1721:45Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/08/1620:11Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/08/1620:09Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/08/1619:59Business WireBristol Myers Squibb and Turning Point Therapeutics Announce Expiration of HSR Act Waiting Period and Clearance from Federal Cartel Office of Germany Related to Pending Acquisition of Turning Point TherapeuticsNASDAQ:TPTXTurning Point Therapeutics Inc
2022/08/1112:20TipRanksAnalysts Offer Insights on Healthcare Companies: Reata Pharmaceuticals (RETA), Turning Point Therapeutics (TPTX) and Talkspace (TALK)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/08/1013:35TipRanksJMP Securities Remains a Hold on Turning Point Therapeutics (TPTX)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/08/0920:07Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/08/0905:20Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/08/0905:19Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/08/0905:17GlobeNewswire Inc.Turning Point Therapeutics Reports Second-Quarter 2022 Financial Results, Provides Operational UpdatesNASDAQ:TPTXTurning Point Therapeutics Inc
2022/08/0112:31TipRanksSVB Securities Maintains a Hold Rating on Turning Point Therapeutics (TPTX)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/07/2805:05GlobeNewswire Inc.Turning Point Therapeutics Provides Regulatory Update for Repotrectinib for the Treatment of ROS1+ Advanced NSCLCNASDAQ:TPTXTurning Point Therapeutics Inc
2022/07/1920:29Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/07/1920:13Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/07/0205:12Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/07/0205:02Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:TPTXTurning Point Therapeutics Inc
2022/06/2422:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TPTXTurning Point Therapeutics Inc
 검색 관련기사 보기:NASDAQ:TPTX

최근 히스토리

AMEX
XLV
Health Care Select Sector
USI
USTECH100
US Tech 100
NYSE
NKE
Nike
COIN
ETHUSD
Ethereum
COIN
SOLUSD
Solana
FX
USDJPY
US Dollar vs Yen
NYSE
AXP
American Express
CCOM
SILVER
SILVER
USOTC
BNPQY
BNP Paribas (QX)
USOTC
BASFY
BASF (QX)
CCOM
US30
US 30
CCOM
US100
US Tech 100
NYSE
DIS
Walt Disney
NASDAQ
MSFT
Microsoft
NYSE
XOM
Exxon Mobil
CCOM
US500
US 500
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유